Also published in GlobeNewswire:
Diverse Slate of Corporate Directors Become NACD Fellows - GlobeNewswire
x hide permanently

Momenta Pharmaceuticals Appoints Dr. Donna Grogan to Board of Directors

GlobeNewswire

CAMBRIDGE, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced the appointment of Donna Grogan, M.D. to its Board of Directors...

Mentions: Momenta Pharmaceuticals, Inc Donna Grogan